SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EARNINGS FLASH L impact

aap Implantate Plans €2 Million Capital Increase, Guides 2026 EBITDA

The company plans a €2 million capital increase and forecasts 2026 EBITDA of -€1 million to +€1.5 million. First Berlin maintained its Buy rating and €1.68 target price. Its report says the portfolio has been MDR-certified since Q1 2026 and anticipates regulatory approval for trauma implants in 2028 or 2029.

AAQ1
SquawkNews Desk

Related stories

Aimtron Electronics Reports 83.32% H1 Revenue Growth Consolidated revenue from operations rose to Rs 224.71 crore in the first half of FY27 from Rs 122.58 crore a year earlier. Consolidated EBITDA increased 80.40% to Rs 54.30 crore f M impact | EARNINGS | Nov 07, 2026, 09:31 AM UTC Innodata Raises 2026 Outlook and Pilots AI Safety, Robotics M impact | EARNINGS | Nov 07, 2026, 08:05 AM UTC Monster Beverage Q3 Sales Rise as Gross Margin Falls to 54.7% M impact | EARNINGS | Nov 07, 2026, 08:05 AM UTC BMPS Lifts FY26 Profit Guidance BMPS also plans an MREL bond sale, while funding reaches €300 billion. M impact | EARNINGS | Nov 07, 2026, 08:04 AM UTC Sabre Lifts EBITDA Outlook as Q3 Growth and United Deal Renewal Reported The headline also notes Q3 growth and a renewed deal with United, but provides no figures or deal terms. M impact | EARNINGS | Nov 07, 2026, 08:03 AM UTC CervoMed Reports Results for Quarter Ended September 30 CervoMed reported quarterly results for the period ended September 30. The supplied text provides no figures. L impact | EARNINGS | Nov 06, 2026, 10:43 PM UTC